explore -WSS

explore

author：knowledge 2025-09-27 09:54:48 - browse：8836

Zepbound, a injectable drug on a gradient background of dark purple and green — biotech coverage from STAT — Illustration: STAT; Source: Eli Lilly/AP

A California biotech developing a combination therapy with the obesity drug Zepbound has raised a $170 million Series D round.

The company, BioAge, raised money from more than a dozen investors. Sofinnova Investments led the round, which also included Eli Lilly and Amgen’s venture arms and previous investor Andreessen Horowitz.

BioAge’s primary focus is in developing medications that boost a person’s healthspan, or the number of healthy years a person lives. The company has drugs in development for neuroinflammation and brain aging. But the majority of the Series D proceeds will be used to develop the company’s lead drug candidate azelaprag, which is being tested in combination with Zepbound. That drug program is what grabbed Sofinnova’s attention, according to managing partner Jim Healy, who recently became chairman of BioAge’s board.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Bright Health sells Medicare Advantage business to Molina
Next article： When prostate cancer spreads, where it goes matters

WSS

Second House panel advances two

Trump's false claims about Georgia's 2020 election long debunked

Glen Campbell's doctor discusses his public struggle with Alzheimer's

Clinical trials must include more disabled people

Arc Institute generative AI designs new CRISPR systems

Trump cancels press conference intended to dispute Georgia election interference charges

hotspot

explore

hotspot

ChatGPT in medicine: STAT answers readers' burning questions

Living with Hashimoto's and celiac disease, and med school, too

Jerome Adams on the need for new antivirals for Covid

Ukraine taking heavy casualties 10 weeks into its counteroffensive

Drug repurposing or repositioning? The language matters

As Maui death toll rises, number of missing remains unclear

At least 13 dead in Texas as scorching temps continue

Venture capitalist Bob Kocher on the state of digital health

Supreme Court strikes down use of affirmative action

Helping hospitals and community health centers plan for resilience

knowledge

Microsoft's Peter Lee says ChatGPT shouldn't be used for initial diagnosis

A neonatal nurse in a British hospital has been found guilty of killing 7 babies

Solving academic medical centers' existential crisis

New definition of a human embryo proposed amid rapid advances

Big Tobacco's 'harm reduction': Is it for real, or a sham?

Congress must give Medicare recipients genetic counseling access

hotspot

knowledge

focus

explore